Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
Related Experiment Video
Updated: Aug 29, 2025

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Valentin Burkart1, Kathrin Kowalski1, David Aldag-Niebling1
1Institute for Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Insights
Transcriptional bursting in sarcomeric genes causes cellular protein and mRNA variations in hypertrophic cardiomyopathy (HCM) patients. This allelic mosaicism contributes to contractile imbalance and disease development.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Cellular Physiology
Background:
- Transcriptional bursting is a prevalent gene expression mechanism.
- Allelic expression variability arises from independent transcription of gene alleles.
- Hypertrophic Cardiomyopathy (HCM) is linked to mutations in sarcomeric proteins.
Purpose of the Study:
- Investigate burst-like transcription of sarcomeric genes (MYBPC3, TNNI3) in HCM.
- Determine the consequences of this transcription mode on allelic mRNA and protein distribution.
- Correlate transcriptional bursting with cardiac contractile function in HCM patients.
Main Methods:
- Fluorescence in situ hybridization (RNA-FISH) to visualize gene transcription.
- Analysis of allelic mRNA ratios in single cardiomyocytes.
- Assessment of wildtype cMyBP-C protein distribution in cardiac tissue.
- Measurement of calcium-dependent force generation in cardiomyocytes.
Main Results:
- MYBPC3 and TNNI3 genes exhibit burst-like transcription in HCM patient cardiac tissue.
- Unequal allelic ratios of TNNI3 mRNA and variable wildtype cMyBP-C protein distribution were observed.
- Mutations caused opposing changes in calcium sensitivity, but all patients showed variable contractile force.
- Significant contractile imbalance was evident among individual cardiomyocytes.
Conclusions:
- Burst-like transcription of sarcomeric genes creates an allelic mosaic at mRNA and protein levels in neighboring cardiomyocytes.
- This mosaicism is a likely contributor to the contractile imbalance observed in HCM.
- Transcriptional bursting and subsequent allelic mosaicism are implicated in the pathogenesis of HCM.
Abstract:
Transcriptional bursting is a common expression mode for most genes where independent transcription of alleles leads to different ratios of allelic mRNA from cell to cell. Here we investigated burst-like transcription and its consequences in cardiac tissue from Hypertrophic Cardiomyopathy (HCM) patients with heterozygous mutations in the sarcomeric proteins cardiac myosin binding protein C (cMyBP-C, MYBPC3) and cardiac troponin I (cTnI, TNNI3). Using fluorescence in situ hybridization (RNA-FISH) we found that both, MYBPC3 and TNNI3 are transcribed burst-like. Along with that, we show unequal allelic ratios of TNNI3-mRNA among single cardiomyocytes and unequally distributed wildtype cMyBP-C protein across tissue sections from heterozygous HCM-patients. The mutations led to opposing functional alterations, namely increasing (cMyBP-Cc.927-2A>G) or decreasing (cTnIR145W) calcium sensitivity. Regardless, all patients revealed highly variable calcium-dependent force generation between individual cardiomyocytes, indicating contractile imbalance, which appears widespread in HCM-patients. Altogether, we provide strong evidence that burst-like transcription of sarcomeric genes can lead to an allelic mosaic among neighboring cardiomyocytes at mRNA and protein level. In HCM-patients, this presumably induces the observed contractile imbalance among individual cardiomyocytes and promotes HCM-development.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology

